Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials

Author: Carlomagno Chiara   Daniele Gennaro   Bianco Roberto   Marciano Roberta   Damiano Vincenzo   Matano Elide   Nappi Lucia   Pepe Stefano   De Placido Sabino   Tortora Giampaolo  

Publisher: Spandidos Publications

ISSN: 1792-0981

Source: Experimental and Therapeutic Medicine, Vol.2, Iss.3, 2011-05, pp. : 449-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content